ESTUTC-5 New YorkLog in Sign up

CATX
Perspective Therapeutics, Inc.
stockNYSEAMERICAN

Market OpenNov 13, 2026 3:28:28 PM EST

0.95USD+12.227%(+0.10)2,518,156

Pre-marketNov 13, 2026 9:25:30 AM EST

0.888701USD+5.496%(+0.046298)

0.8000Bid0.9400Ask0.1400Spread

CATX News

Day breaks

09:01 AM ESTPerspective Therapeutics CMO Markus Puhlmann buys $34,544 in stock ·

Investing.com

11:37 AM ESTCATX Maintained by Truist Securities -- Price Target Lowered to $8.00 ·

GuruFocus

11:01 AM ESTCATX Maintained by Wedbush -- Price Target Lowered to $7.00 ·

GuruFocus

08:53 AM ESTBMO reiterates Outperform on Perspective Therapeutics stock ·

Investing.com

08:45 AM ESTCATX Maintained by Piper Sandler -- Price Target Lowered to $8.00 ·

GuruFocus

05:52 AM ESTTruist cuts Perspective Therapeutics stock price target on timeline ·

Investing.com

05:52 AM ESTWedbush lowers Perspective Therapeutics stock price target to $7 ·

Investing.com

09:18 PM ESTPerspective Therapeutics earnings missed by $0.03, revenue fell short of estimates ·

Investing.com

06:10 PM ESTPerspective Therapeutics Inc Reports Q3 2026: Net Loss of $32. ... ·

GuruFocus

04:36 PM ESTPerspective Therapeutics GAAP EPS of -$0.27 misses by $0.02, revenue of $0.02M misses by $0.03M ·

Seeking Alpha

04:30 PM ESTPerspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2026 Results ·

GlobeNewswire Inc.

01:25 PM ESTPerspective Therapeutics (CATX) Reports Interim Phase 1/2a Data on Targeted Alpha Therapy ·

GuruFocus

12:00 PM ESTPerspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026 ·

GlobeNewswire Inc.

09:50 PM ESTPerspective Therapeutics (CATX) Shares New Phase 1/2a Data on Targeted Alpha Therapy for ... ·

GuruFocus

08:10 PM ESTPerspective Therapeutics Presents Encouraging Incremental Data and Analyses from Phase 1/2a Trial of [212Pb]Bamzireotide Navoxetan (VMT-α-NET) in Advanced SSTR2 Expressing NETs ·

GlobeNewswire Inc.

08:55 AM ESTCatalyst One to Acquire BC Rare Earth Property from LIRECA Resources Inc. ·

Newsfile

12:30 AM ESTTelix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics ·

PR Newswire

06:04 AM EDTBTIG reiterates Buy on Perspective Therapeutics stock after data ·

Investing.com

05:52 AM EDTRBC Capital downgrades Perspective Therapeutics stock rating on trial data ·

Investing.com

10:49 AM EDTPerspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs ·

GlobeNewswire Inc.